Inventor · disambiguated record
Sylvia Degrado
Also filed as: DEGRADO SYLVIA · DEGRADO SYLVIA J · DEGRADO SYLVIA JOANNA
7 granted patents·2 pending applications·18 citations·filing 2006–2019
77Inventor score
Files withCELLERANT THERAPEUTICS INC2SCHERING CORP2BOYCE CHRISTOPHER W1MERCK SHARP & DOHME1PALANI ANANDAN1
Top patents by PatentIndex Score
9 records- 0183US7763623B2Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemiaSCHERING CORP·Filed 2007·Granted Jul 27, 2010·9 cites·39 claims
- 0277US10138212B2Aminoquinazoline compounds as A2A antagonistMERCK SHARP & DOHME·Filed 2016·Granted Nov 27, 2018·2 cites·18 claims
- 0374US7750015B2Nitrogen-containing heterocyclic compounds and methods of use thereofSCHERING CORP·Filed 2006·Granted Jul 6, 2010·2 cites·47 claims
- 0472US9469615B2Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulatorsBOYCE CHRISTOPHER W·Filed 2011·Granted Oct 18, 2016·4 cites·27 claims
- 0571US10350218B2Isoquinolidinobenzodiazepine (IQB)-1(chloromethyl)-2,3-dihydro-1H-benzo[e]indole (CBI) dimersCELLERANT THERAPEUTICS INC·Filed 2018·Granted Jul 16, 2019·1 cites·11 claims
- 0650US2020061079A1Isoquinolidinobenzodiazepine (iqb)-1(chloromethyl)-2,3-dihydro-1h-benzo[e]indole (cbi) dimersCELLERANT THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0735US10654873B2Cytotoxic agents and conjugates thereofPOLYTHERICS LTD·Filed 2017·Granted May 19, 2020·0 cites·32 claims
- 0830US2011207734A1Azine Derivatives and Methods of Use ThereofPALANI ANANDAN·Filed 2011·Application pending·0 cites
- 0928US8598158B2Fused tricyclic compounds for the treatment of inflammatory disordersXIAO DONG·Filed 2010·Granted Dec 3, 2013·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Sylvia Degrado files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →